Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lymphopenic infectious mononucleosis.

R S Bar, J Adlard, F B Thomas

    Archives of Internal Medicine
    |February 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Lymphopenic infectious mononucleosis (IM) presents as a severe illness with a poorer prognosis than typical IM. This condition warrants inclusion in the clinical spectrum of IM, supported by diagnostic antibody titers.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pulaski County (Ind.) Medical Society.

    Chicago medical examiner·2023
    Same author

    Pulaski County (Ind.) Medical Society.

    The Chicago medical journal·2023
    Same author

    Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study.

    British journal of cancer·2012
    Same author

    Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2.

    British journal of cancer·2011
    Same author

    A screw-holding screwdriver.

    Lancet (London, England)·2010
    Same author

    Screening for metastases after surgical treatment for breast cancer: an audit of practice in three district general hospitals.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2005
    Same journal

    Elevated CK-MB With Normal Total Creatine Kinase Levels in Patients Undergoing Maintenance Hemodialysis-Reply.

    Archives of internal medicine·2017
    Same journal

    Occult Carbon Monoxide Poisoning-Reply.

    Archives of internal medicine·2017
    Same journal

    Acquired Immune Deficiency Syndrome-Reply.

    Archives of internal medicine·2017
    Same journal

    Heparin Side Effects-Reply.

    Archives of internal medicine·2017
    Same journal

    Humanizing primary care medicine begins with stress.

    Archives of internal medicine·2017
    Same journal

    Legend omitted and number misrepresented.

    Archives of internal medicine·2013
    See all related articles

    Area of Science:

    • Infectious Diseases
    • Hematology
    • Immunology

    Background:

    • Infectious mononucleosis (IM) is typically a benign illness.
    • A subset of IM patients exhibit lymphopenia, a condition not fully characterized.
    • The clinical significance and prognosis of lymphopenic IM remain areas for further investigation.

    Purpose of the Study:

    • To establish lymphopenic infectious mononucleosis (IM) as a distinct clinical entity.
    • To describe the clinical presentation and prognosis of lymphopenic IM.
    • To recommend diagnostic criteria for lymphopenic IM.

    Main Methods:

    • Retrospective analysis of clinical data from IM patients.
    • Comparison of clinical severity and outcomes between lymphopenic and non-lymphopenic IM cohorts.

    Related Experiment Videos

  • Serological testing for Epstein-Barr virus (EBV) and heterophil antibodies.
  • Main Results:

    • Lymphopenic IM is a recognized clinical phenomenon.
    • Patients with lymphopenic IM often present with more severe illness compared to typical IM.
    • Lymphopenic IM is associated with a poorer prognosis than typical IM.

    Conclusions:

    • The clinical spectrum of IM should be expanded to include lymphopenic presentations.
    • Diagnosis of lymphopenic IM requires confirmation with heterophil and EBV antibody titers.
    • Recognition of lymphopenic IM is crucial for appropriate patient management and prognosis assessment.